These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9495594)

  • 1. Interruption of T-cell signal transduction by lentivirus lytic peptides from HIV-1 transmembrane protein.
    Beary TP; Tencza SB; Mietzner TA; Montelaro RC
    J Pept Res; 1998 Jan; 51(1):75-9. PubMed ID: 9495594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational site-directed mutations of the LLP-1 and LLP-2 lentivirus lytic peptide domains in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41 indicate common functions in cell-cell fusion but distinct roles in virion envelope incorporation.
    Kalia V; Sarkar S; Gupta P; Montelaro RC
    J Virol; 2003 Mar; 77(6):3634-46. PubMed ID: 12610139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein.
    Miller MA; Mietzner TA; Cloyd MW; Robey WG; Montelaro RC
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1057-66. PubMed ID: 8312049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viroporin potential of the lentivirus lytic peptide (LLP) domains of the HIV-1 gp41 protein.
    Costin JM; Rausch JM; Garry RF; Wimley WC
    Virol J; 2007 Nov; 4():123. PubMed ID: 18028545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane structure correlates to function of LLP2 on the cytoplasmic tail of HIV-1 gp41 protein.
    Boscia AL; Akabori K; Benamram Z; Michel JA; Jablin MS; Steckbeck JD; Montelaro RC; Nagle JF; Tristram-Nagle S
    Biophys J; 2013 Aug; 105(3):657-66. PubMed ID: 23931314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of amino acid substitutions on calmodulin binding and cytolytic properties of the LLP-1 peptide segment of human immunodeficiency virus type 1 transmembrane protein.
    Tencza SB; Miller MA; Islam K; Mietzner TA; Montelaro RC
    J Virol; 1995 Aug; 69(8):5199-202. PubMed ID: 7609094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synthetic peptide with sequence identity to the transmembrane protein GP41 of HIV-1 inhibits distinct lymphocyte activation pathways dependent on protein kinase C and intracellular calcium influx.
    Ruegg CL; Strand M
    Cell Immunol; 1991 Oct; 137(1):1-13. PubMed ID: 1832084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calmodulin binding properties of peptide analogues and fragments of the calmodulin-binding domain of simian immunodeficiency virus transmembrane glycoprotein 41.
    Yuan T; Tencza S; Mietzner TA; Montelaro RC; Vogel HJ
    Biopolymers; 2001 Jan; 58(1):50-62. PubMed ID: 11072229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HIV gp41 Fusion Protein Inhibits T-Cell Activation through the Lentiviral Lytic Peptide 2 Motif.
    Klug YA; Schwarzer R; Rotem E; Charni M; Nudelman A; Gramatica A; Zarmi B; Rotter V; Shai Y
    Biochemistry; 2019 Feb; 58(6):818-832. PubMed ID: 30602116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Transmembrane Domain of HIV-1 gp41 Inhibits T-Cell Activation by Targeting Multiple T-Cell Receptor Complex Components through Its GxxxG Motif.
    Rotem E; Reuven EM; Klug YA; Shai Y
    Biochemistry; 2016 Feb; 55(7):1049-57. PubMed ID: 26828096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calmodulin-binding function of LLP segments from the HIV type 1 transmembrane protein is conserved among natural sequence variants.
    Tencza SB; Mietzner TA; Montelaro RC
    AIDS Res Hum Retroviruses; 1997 Feb; 13(3):263-9. PubMed ID: 9115814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 gp41 and TCRalpha trans-membrane domains share a motif exploited by the HIV virus to modulate T-cell proliferation.
    Cohen T; Cohen SJ; Antonovsky N; Cohen IR; Shai Y
    PLoS Pathog; 2010 Sep; 6(9):e1001085. PubMed ID: 20824090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the interacting domain of the HIV-1 fusion peptide with the transmembrane domain of the T-cell receptor.
    Cohen T; Pevsner-Fischer M; Cohen N; Cohen IR; Shai Y
    Biochemistry; 2008 Apr; 47(16):4826-33. PubMed ID: 18376816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 fusion protein exerts complex immunosuppressive effects.
    Ashkenazi A; Faingold O; Shai Y
    Trends Biochem Sci; 2013 Jul; 38(7):345-9. PubMed ID: 23685134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein.
    Haynes BF; Arthur LO; Frost P; Matthews TJ; Langlois AJ; Palker TJ; Hart MK; Scearce RM; Jones DM; McDanal C
    J Exp Med; 1993 Mar; 177(3):717-27. PubMed ID: 7679708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of protein kinase C and anti-CD3-induced Ca2+ influx in Jurkat T cells by a synthetic peptide with sequence identity to HIV-1 gp41.
    Ruegg CL; Strand M
    J Immunol; 1990 May; 144(10):3928-35. PubMed ID: 2139676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.
    Chen SS; Lee SF; Wang CT
    J Virol; 2001 Oct; 75(20):9925-38. PubMed ID: 11559825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell inactivation and immunosuppressive activity induced by HIV gp41 via novel interacting motif.
    Bloch I; Quintana FJ; Gerber D; Cohen T; Cohen IR; Shai Y
    FASEB J; 2007 Feb; 21(2):393-401. PubMed ID: 17185749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic peptide corresponding to the carboxy terminus of human immunodeficiency virus type 1 transmembrane glycoprotein induces alterations in the ionic permeability of Xenopus laevis oocytes.
    Comardelle AM; Norris CH; Plymale DR; Gatti PJ; Choi B; Fermin CD; Haislip AM; Tencza SB; Mietzner TA; Montelaro RC; Garry RF
    AIDS Res Hum Retroviruses; 1997 Nov; 13(17):1525-32. PubMed ID: 9390752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gp41 dynamically interacts with the TCR in the immune synapse and promotes early T cell activation.
    Yakovian O; Schwarzer R; Sajman J; Neve-Oz Y; Razvag Y; Herrmann A; Sherman E
    Sci Rep; 2018 Jun; 8(1):9747. PubMed ID: 29950577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.